Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Precise Research Centers
mi
from
Flowood, MS
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Precise Research Centers
mi
from
Flowood, MS
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Heartland Pharma Developments
mi
from
North Platte, NE
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Heartland Pharma Developments
mi
from
North Platte, NE
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Creighton University
mi
from
Omaha, NE
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Center for Psychiatry and Behavioral Medicine, Incorporated
mi
from
Las Vegas, NV
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Center for Psychiatry and Behavioral Medicine, Incorporated
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Nina F. Wimpie, MD Pediatrics
mi
from
Middleburg Heights, OH
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Nina F. Wimpie, MD Pediatrics
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
IPS Research Company
mi
from
Oklahoma City, OK
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Summit Research Network (Oregon), Incorporated
mi
from
Portland, OR
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Summit Research Network (Oregon), Incorporated
mi
from
Portland, OR
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Focus and Balance, LLC
mi
from
San Antonio, TX
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Focus and Balance, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
The Rogers Center for Research & Training, Inc.
mi
from
Milwaukee, WI
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
The Rogers Center for Research & Training, Inc.
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
ATP Clinical Research, Inc. 1
mi
from
Costa Mesa, CA
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc. 1
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center (New)
mi
from
Cincinnati, OH
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center (New)
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Cutting Edge Research Group
mi
from
Oklahoma City, OK
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Paradigm Research Professionals, Llc
mi
from
Oklahoma City, OK
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Paradigm Research Professionals, Llc
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Hospital Aranda de la Parra, S.A. de C.V.
mi
from
Leon,
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Hospital Aranda de la Parra, S.A. de C.V.
mi
from
Leon,
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Midwest Research Group
mi
from
Saint Charles, MO
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
The Treatment of Depression With Botulinum Type A Toxin
The Treatment of Depression With Botulinum Type A Toxin (Botox): A Randomized, Double Blind, Crossover Study
Status: Enrolling
Updated:  12/31/1969
Seton Mind Institute: Medical Park Tower
mi
from
Austin, TX
The Treatment of Depression With Botulinum Type A Toxin
The Treatment of Depression With Botulinum Type A Toxin (Botox): A Randomized, Double Blind, Crossover Study
Status: Enrolling
Updated: 12/31/1969
Seton Mind Institute: Medical Park Tower
mi
from
Austin, TX
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital Boston
mi
from
Boston, MA
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
Columbia Univerisity New York City
mi
from
New York, NY
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
Columbia Univerisity New York City
mi
from
New York, NY
Click here to add this to my saved trials
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Tuscaloosa VA Medical Center, Tuscaloosa, AL
mi
from
Tuscaloosa, AL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Tuscaloosa VA Medical Center, Tuscaloosa, AL
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Phoenix VA Health Care System, Phoenix, AZ
mi
from
Phoenix, AZ
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Phoenix VA Health Care System, Phoenix, AZ
mi
from
Phoenix, AZ
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Southern Arizona VA Health Care System, Tucson
mi
from
Tucson, AZ
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Southern Arizona VA Health Care System, Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Loma Linda Healthcare System, Loma Linda, CA
mi
from
Loma Linda, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Loma Linda Healthcare System, Loma Linda, CA
mi
from
Loma Linda, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Long Beach Healthcare System, Long Beach, CA
mi
from
Long Beach, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Long Beach Healthcare System, Long Beach, CA
mi
from
Long Beach, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
mi
from
Denver, CO
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
mi
from
Denver, CO
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Miami VA Healthcare System, Miami, FL
mi
from
Miami, FL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Miami VA Healthcare System, Miami, FL
mi
from
Miami, FL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
James A. Haley Veterans' Hospital, Tampa, FL
mi
from
Tampa, FL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
James A. Haley Veterans' Hospital, Tampa, FL
mi
from
Tampa, FL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Kansas City VA Medical Center, Kansas City, MO
mi
from
Kansas City, MO
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Kansas City VA Medical Center, Kansas City, MO
mi
from
Kansas City, MO
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
mi
from
Omaha, NE
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
mi
from
Omaha, NE
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Asheville VA Medical Center, Asheville, NC
mi
from
Asheville, NC
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Asheville VA Medical Center, Asheville, NC
mi
from
Asheville, NC
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
mi
from
Salisbury, NC
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
mi
from
Salisbury, NC
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
Click here to add this to my saved trials